THE PFIZER FOUNDATION INC
Advancing Care for Patients with Advanced ALK+ Non-Small Cell Lung Cancer (NSCLC) Grant
Advancing Care for Patients with Advanced ALK+ Non-Small Cell Lung Cancer (NSCLC) Grant is a funding opportunity from THE PFIZER FOUNDATION INC, up to $100.0K. Its application deadline is not stated in the source record.
We could not verify this deadline.
This listing carries no application deadline we can confirm, so it may no longer be open. Check the official solicitation before investing time, and create a free account to see opportunities we can verify are live.
Overview
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies. Advancing Care for Patients with Advanced ALK+ Non-Small Cell…